Professional Documents
Culture Documents
MALAYSI
A
WHO
QUALITY
REPORTS
HOW?
Drug suspected?
Check literature
Highly suggestive of
ADR
Not documented in literature
Symptoms improve
Worsening of (+ve dechallenge)
symptoms
Drug restarted
REPORTING MECHANISM
Directly by the prescribers
Through the pharmacists
Through the drug companies
CAUSALITY
ASSESSMENT OF
SUSPECTED ADVERSE
DRUG REACTION
INTRODUCTION
C1 – Certain
C2 – Probable
C3 – Possible
C4 – Unlikely
C5 – Unclassifiable
WHO Causality Categories
C1: Plausible time, not related to
underlying condition, concurrent
disease, other drugs or chemicals,
related pharmacologically, +ve
dechallenge, +ve rechallenge
C2: Reasonable time, unlikely to be
related to concurrent disease, other
drugs,+ve dechallenge, no rechallenge
CAUSALITY ASSESSMENT
C3: Reasonable time, may be due to
concurrent disease, other drugs, no
information on dechallenge
C4: Improbable temporal relationship,
other confounding factors such as
drugs, chemicals, underlying disease
C5: Insufficient information to analyse
the report
Case causality
assessment
How close is the relationship
between drug and event?
Did the drug cause the
event?
CONSUMERS
MEDICINES
SURVEILLANCE
The protocol for the medicines
surveillance integrating
consumer reporting
The surveillance of medicines
integrating consumer reporting will be
an extension and expansion of the
existing surveillance activities carried
out by NPCB
NPCB will be the focal point which will
receive, analyze and investigate the
reports submitted by the consumers.
The importance of involving
consumer in medicines surveillance
The ultimate goal is to improve the
quality, efficacy and safety of the
marketed product
Empower consumers to be aware of
Quality
Safety
Correct usage of medication
Alleviate the problem of consumers
wasting their valuable resources on
medicines which may expose their
health to risks.
Reporting by consumers can be done
through
Reporting forms
On-line reporting
Other channels eg: letters, phone calls,
emails and complaints done personally to
Drug Regulatory Agencies (DRA)
Information channeled through health
professionals, the product owner, consumer
associations or other trade and industry
organizations which will then be directed to
NPCB
What to report?
Quality defects
Lack of efficacy
Adverse drug reactions
Suspected counterfeit product
Unregistered product
Suspected adulterated products
Medication error / near misses
Fraudulent / misleading claims
WORK PROCESS
Receive product complaint
Eg : seizures,
thrombocytopenia, hypotonic
hyporesponsive episodes,
persistent inconsolable
screaming, anaphylaxis,
paralytic poliomyelitis,
disseminated BCG infection
Prevention and Treatment
Occurring within 15 · Seizures, including febrile seizures (6-12 days for measles/MMR; 0-2 days for DTP)
· Encephalopathy (6-12 days for measles/MMR; 0-2 days for DTP)
days of immunization
Occurring within 3 · Acute flaccid paralysis (4-30 days for OPV recipient; 4-75 days for contact)
· Brachial neuritis (2-28 days after tetanus containing vaccine)
months of immunization · Thrombocytopenia (15-35 days after measles/MMR)
Doctors/Pharmacists/Industries
Stimulates report, investigates, filters,
provides feedback, proposes classification
When to report?
Immediately
Reporting AEFIs
How to report?
ON-LINE REPORTING
www.bpfk.gov.my
MANUAL
When to investigate?
As soon as practicable
Why local reports are
important?
Differ among countries in the occurrence
of AEFIs and other related problems
Due to differences
diseases and prescribing practices
genetics, diet, traditions
A 3-month old female child was vaccinated with a second dose of Pediacel which
contains DPT/Polio/HIB on 29th December 2006 at 9.50am. The child developed
lethargy, poor feeding and intermittent cry with no fever in the afternoon of the
vaccination day.
The child was only brought back to the clinic on 30th December 2006 at about
4.20pm in near collapse condition. The child was pallor with perfusion > 3 second,
heart rate 100/min, poor pulse volume and poor lung function. She was
resuscitated at the clinic but collapsed at 5.45pm. CPR was given for about one
hour but unfortunately the child passed away at 6.45pm. Her body was sent to
Hospital Kajang.
The post mortem was done in Hospital Kajang and the result shown she died due to
Acute Lymphocytic Infiltration to Heart and Mild Endocarditis (viral).
This report was sent to MADRAC on 3rd January 2007. The reporter also reported
that the child was well prior to the 1st dose of Pediacel.
CASE REPORT ON TRITANRIX HB – HiB VACCINE
A 3 month old infant received the 2nd dose Tritanrix HB – HiB and OPV Vaccine given at
Klinik Desa Mata Air. The vaccine was administered intramuscularly into left thigh at around
9am on the 18/06/2008.
Within 2 hours after administration, the baby started crying excessively and soon collapsed.
She was immediately brought to Hospital Tuanku Fauziah, where she was confirmed dead
upon arrival at the hospital.
Previous exposure, 1st dose vaccination with the same vaccine did not result in any adverse
event. The baby was otherwise well with no significant background medical history or known
allergies.
From the post mortem and toxicology findings, the cause of death was interstitial pneumonia.
There is no objective evidence showed the possibility of fatal anaphylaxis reaction
towards the vaccine.
Information from the WHO Immunization Safety Programme, showed the expected rate for
“crying abnormal” and “collapsed” after vaccinated with the DTP was 1/100 dose and
1/1750 doses respectively.
After the discussion, MADRAC agreed that the adverse event “crying abnormal” and
“collapsed” cause by the vaccine. Causality C1 (certain) had been given for the reaction
because, there was no other concomitant drug given together with the vaccine, with a
plausible temporal relation time and there was no other underlying disease which can be
link to the ADR.
CASE REPORT - Pentaxim and Euvax
2 month old male infant received the 1st dose of DTAP-IPV given at Klinik
Kesihatan WP Labuan. The vaccine was administered on 12/1/2009 (time was
unknown). The baby then developed low grade fever at 12.00 noon on the same
day and 1.5mls Syrup Paracetamol given. The baby fed as usual after that. The
mother then noticed that the baby had an injection site swelling and the mother
put a warm compress at the injection site.
The baby was again given Paracetamol Syrup at 8 pm and a last dose at 4 am.
The mother noticed that the infant choked a little after the administration of the
last dose of paracetamol and had fed the child immediately after giving the
medicine. Mother and child went to sleep. At around 6 am the mother found that
the baby was not moving, looked pale and had bleeding from the ears and nose.
The parents brought the baby to the Hospital WP Labuan at 7.50 am. At the
A&E Department the baby was found to have already stopped breathing. The
parents refused to do a postmortem.
140 132
120
100
75
80 68
BIL. LAPORAN VAKSIN
60 52
39
40 26
14 10 13
20
0
2000 2001 2002 2003 2004 2005 2006 2007 2008
TAHUN
T R E N D L A P O R A N A D R D A N V A K S IN
6000
5000 4826
4000
BIL. LAPORAN
B IL . L A P O R A N A D R
3000 3068
2 3 6 32 5 4 3 B IL . L A P O R A N V A K S IN
2000
1665
1000 792 787 1 0 0 01 0 6 3
0 14 10 26 13 52 68 39 75 132
2 0 0 02 0 0 12 0 0 22 0 0 32 0 0 42 0 0 52 0 0 62 0 0 72 0 0 8
T AH U N
THANK YOU